Purchases and Sales Made in Q4 2022 in Rocket Pharmaceuticals, Inc. (RCKT)
This table provides information about the institutional ownership of Rocket Pharmaceuticals, Inc. (RCKT) during Q4 2022. The information is specifically focused on institutions that hold shares of ROCKET PHARMACEUTICALS, INC..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Feb 14, 2023
Q4 2022
|
D. E. Shaw & Co., Inc.
New York, NY |
SELL
|
- |
-266K- 59.37% |
$4.13M - $6.06M
|
182K
$1.68M
|
|
|
Feb 14, 2023
Q4 2022
|
Two Sigma Investments, LP
New York, NY |
SELL
|
- |
-267K- 78.78% |
$4.14M - $6.08M
|
72K
$663K
|
|
|
Feb 13, 2023
Q4 2022
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
SELL
|
- |
-321K- 66.9% |
$4.98M - $7.31M
|
159K
$1.46M
|
|
|
Feb 14, 2023
Q4 2022
|
Ally Bridge Group (Ny) LLC
New York, NY |
SELL
|
- |
-354K- 73.89% |
$5.49M - $8.06M
|
125K
$1.15M
|
|
|
Jan 12, 2023
Q4 2022
|
Assenagon Asset Management S.A.
|
SELL
|
- |
-380K- 27.41% |
$5.88M - $8.64M
|
1.01M
$9.26M
|
|
|
Feb 14, 2023
Q4 2022
|
Health Cor Management, L.P.
New York, NY |
SELL
|
- |
-395K- 88.77% |
$6.12M - $8.99M
|
50K
$461K
|
|
|
Feb 14, 2023
Q4 2022
|
Morgan Stanley
New York, NY |
SELL
|
- |
-662K- 55.32% |
$10.3M - $15.1M
|
534K
$4.92M
|
|
|
May 14, 2024
Q4 2022
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-1.01M- 49.47% |
$15.6M - $22.9M
|
1.03M
$9.48M
|
|
|
Feb 13, 2023
Q4 2022
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-1.01M- 49.47% |
$15.6M - $22.9M
|
1.03M
$9.48M
|